Skip to content

Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Cardiac Surgery

Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Cardiac Surgery: A Randomized Double-blinded Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07604623
Enrollment
90
Registered
2026-05-22
Start date
2026-09-01
Completion date
2028-06-30
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unilateral Vocal Cord Paralysis, Unilateral Vocal Cord Paresis

Keywords

unilateral vocal cord paralysis, unilateral vocal fold immobility, laryngeal nerve injury, recurrent laryngeal nerve injury

Brief summary

This research studies whether a device used during surgery can help doctors better protect the nerve that moves a child's vocal cords. Damage to this nerve can affect speaking, swallowing, and sometimes breathing. Children having certain throat, chest, or heart surgeries may be asked to take part. During surgery, some children will have standard care and others will have standard care plus the nerve-monitoring device. After surgery, the team will check vocal cord movement and ask about voice and swallowing. The purpose is to see whether the device can lower the chance of nerve injury and improve care for children in the future.

Detailed description

Purpose The purpose of this study is to compare the rate of recurrent laryngeal nerve (RLN) injury in pediatric patients undergoing aerodigestive and cardiac surgeries with intraoperative laryngeal nerve monitoring (IOLNM) versus standard surgery without IOLNM. The study also aims to evaluate whether continuous electromyography monitoring reduces clinically detectable postoperative nerve dysfunction in children undergoing RLN-risk surgery. Hypothesis The investigators hypothesize that patients who undergo surgery with IOLNM will have a lower rate of RLN injury, less severe nerve injury when injury occurs, and a shorter duration of neuropraxia/vocal cord paresis compared with patients who undergo standard surgery without monitoring. Justification Vocal cord paralysis is a recognized complication of pediatric thyroid, airway, esophageal, and cardiac surgery because the RLN is vulnerable along its course through the neck and chest. RLN injury can lead to dysphonia, dysphagia, aspiration, and respiratory insufficiency, making prevention clinically important. Existing evidence suggests IOLNM may reduce RLN injury, especially in pediatric surgery where some procedures have reported injury rates as high as 40%; however, the current literature is limited by a lack of prospective randomized studies and lack of direct prospective comparison against standard surgical care. The recent availability of pediatric-compatible monitoring electrodes also makes this question feasible to study in infants and young children. Research Method/Procedures This is a single-centre, randomized, double-blinded, controlled clinical trial conducted at Stollery Children's Hospital. Eligible participants are patients under 18 years of age undergoing RLN-risk surgery involving the trachea, esophagus, thyroid, mediastinum, ductus arteriosus, or aortic arch, with specified inclusion and exclusion criteria. Participants, study investigators, clinicians performing follow-up flexible laryngoscopy, and video raters are blinded to allocation; surgeons and personnel directly involved in intraoperative care cannot be blinded. For participants randomized to the intervention arm, IOLNM is used during a single surgery. Surgery otherwise proceeds according to standard of care. Within four weeks of their surgery, participants are seen in follow-up by Dr. Isaac or another pediatric otolaryngologist. At that visit, they complete the PedsQL, PVRQOL, Pediatric VHI, and dysphagia questionnaires, and undergo video-recorded flexible fiberoptic laryngoscopy. The recorded laryngoscopy is anonymized and reviewed by a blinded independent expert. For patients with RLN injury, further clinical follow-up and repeat laryngoscopy every three months for at least one year or until recovery occur as part of standard care. Safety monitoring is performed during surgery, the postoperative hospital stay, and follow-up visits. Adverse events related to IOLNM include, but are not limited to, laryngeal trauma, airway bleeding, or inflammation, and are reported to the study coordinator, principal investigator, and local HREB in accordance with institutional and Health Canada standards.

Interventions

OTHERIntraoperative laryngeal nerve monitor

This nerve monitor will notify surgeons if the recurrent laryngeal nerve is at risk for damage during surgery, by signalling if the nerve is being stretched or manipulated throughout the procedure.

Sponsors

University of Alberta
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* under 18 years of age * treated at the Stollery Children's Hospital * will undergo specified aerodigestive or cardiac surgeries that put the recurrent laryngeal nerve at risk

Exclusion criteria

* patients treated at another center * over 18 years of age at the time of surgery * severe neurological or genetic comorbidities that affect nerve function

Design outcomes

Primary

MeasureTime frameDescription
Vocal fold mobilityFlexibly laryngoscopy will be performed within four weeks of the aerodigestive or cardiac surgery.Vocal fold mobility will be assessed by flexible laryngoscopy on patients post operatively to determine if there has been RLN injury resulting in vocal cord immobility.

Secondary

MeasureTime frameDescription
Impact on voice in UVFI patientsThe questionnaire will be given within four weeks of the UVFI diagnosis.Voice-related quality of life questionnaire
Severity of dysphonia in UVFI patientsVoice assessment will be completed within four weeks of UVFI diagnosisDysphonia measured by acoustic analysis and GRBAS assessment
Swallowing outcomes in UVFI patientsSwallowing assessments will be completed within four weeks of UVFI diagnosis and as recommended by SLP/ENTDysphagia will be measured by FEES and/or VFSS assessments
Swallowing symptom burden in UVFI patientsQuestionnaires will be given within four weeks of UVFI diagnosisImpact on quality of life from dysphagia will be measured using validated questionnaires
Rate of spontaneous resolution of UVFIThese outcomes will be measured by flexible laryngoscopy at 3 month and 6 month intervals after the time of UVFI diagnosisRate of vocal fold motion recovery, and time to recovery, assessed by flexibly laryngoscopy

Countries

Canada

Contacts

CONTACTAndre Isaac
aisaac@ualberta.ca17804071449

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026